News
The multiple sclerosis (MS) disease-modifying therapy (DMT) market across the seven major markets (7MM: the US, France, ...
In multiple sclerosis (MS), an alteration of neuronal metabolism caused by dysfunction of its proteasome, the cellular machinery responsible for recycling proteins, contributes to neurodegeneration in ...
TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY. Click to learn about TGTX growth, upcoming trials, and ...
Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...
The (MSAA) is pleased to provide vital services and resources to individuals affected by MS, their families, and care ...
More than 90% of RRMS patients given vidofludimus calcium in a clinical trial were free of confirmed disability worsening ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Recent highlights in MS coverage focus on biomarkers, pregnancy, and neurodegeneration. Physician’s Weekly has compiled a ...
A new technology that uses clinical MRI machines to image metabolic activity in the brain could give researchers and ...
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says.
A blood test might predict when multiple sclerosis patients are about to suffer a relapse in their symptoms, a new study says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results